Table 3

Medication use in selected population

CT-first (n=2308)Patients without a CT-first strategy (n=10 237)
Aspirin (%)
 Continued57 (2.5)323 (3.2)
 Discontinued22 (1.0)40 (0.4)
 Initiated1036 (44.9)2770 (27.1)
 Initiated and discontinued339 (14.7)369 (3.6)
Beta-blocker (%)
 Continued75 (3.2)419 (4.1)
 Discontinued20 (0.9)23 (0.2)
 Initiated873 (37.8)2611 (25.5)
 Initiated and discontinued549 (23.8)525 (5.1)
Calcium-channel blocker (%)
 Continued36 (1.6)135 (1.3)
 Discontinued<10 (<0.4)13 (0.1)
 Initiated287 (12.4)1311 (12.8)
 Initiated and discontinued81 (3.5)213 (2.1)
Nitrates (%)
 Continued18 (0.8)92 (0.9)
 Discontinued<10 (<0.4)<10 (<0.1)
 Initiated502 (21.8)1791 (17.5)
 Initiated and discontinued165 (7.1)260 (2.5)
Statins (%)
 Continued71 (3.1)332 (3.2)
 Discontinued<10 (<0.4)<10 (<0.1)
 Initiated1125 (48.7)3102 (30.3)
 Initiated and discontinued84 (3.6)141 (1.4)
  • Medication use in selected patients for the CT-first strategy and patients without a CT-first strategy. Continued medication is defined as medication that was started before the chest pain consult and continued for at least 120 following days. Discontinued medication is medication started before the consult and stopped within 120 days. Initiated medication was started within the time frame from chest pain consult until 120 days after the consult. Initiated and discontinued medication was medication that was started and discontinued within 120 days following the chest pain consult.